Sinoma Science & Technology Co.,Ltd. (SHE:002080)
China · Delayed Price · Currency is CNY 40.97
+0.89 (2.22%)
Mar 30, 2026, 12:54 PM CST
SHE:002080 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 29,578 | 23,206 | 25,189 | 25,196 | 19,856 |
Other Revenue | 617.62 | 777.55 | 703.59 | 617.95 | 439.51 |
| 30,195 | 23,984 | 25,893 | 25,814 | 20,295 | |
Revenue Growth (YoY) | 25.90% | -7.37% | 0.30% | 27.19% | 7.58% |
Cost of Revenue | 24,594 | 19,981 | 19,913 | 19,823 | 14,267 |
Gross Profit | 5,601 | 4,002 | 5,980 | 5,991 | 6,028 |
Selling, General & Admin | 1,779 | 1,606 | 1,590 | 1,487 | 1,259 |
Research & Development | 1,498 | 1,271 | 1,302 | 1,209 | 961.49 |
Other Operating Expenses | 260.83 | -403.18 | 221.1 | -162.78 | 115.79 |
Operating Expenses | 3,594 | 2,544 | 3,140 | 2,550 | 2,337 |
Operating Income | 2,007 | 1,458 | 2,840 | 3,442 | 3,691 |
Interest Expense | -365.28 | -396.4 | -404.35 | -501.1 | -459.03 |
Interest & Investment Income | 40.38 | 110.01 | 61.46 | 171.33 | 72.23 |
Currency Exchange Gain (Loss) | 4.7 | 18.01 | 28.96 | 93.17 | -36.43 |
Other Non Operating Income (Expenses) | -23.75 | -10.88 | -56.44 | -21.77 | 4.11 |
EBT Excluding Unusual Items | 1,663 | 1,179 | 2,469 | 3,183 | 3,272 |
Gain (Loss) on Sale of Investments | -2.08 | -0.82 | -14.26 | 13.22 | - |
Gain (Loss) on Sale of Assets | 149.85 | 2.77 | 62.35 | 1,078 | 680.95 |
Asset Writedown | -113.52 | -15.35 | -21.89 | -139.09 | -82.5 |
Legal Settlements | - | - | - | - | -8 |
Other Unusual Items | 648.27 | 21.19 | 535.23 | 14.41 | 251.28 |
Pretax Income | 2,346 | 1,221 | 3,037 | 4,153 | 4,124 |
Income Tax Expense | 257.05 | 96.63 | 321.71 | 323.35 | 648.52 |
Earnings From Continuing Operations | 2,089 | 1,124 | 2,715 | 3,830 | 3,475 |
Net Income to Company | 2,089 | 1,124 | 2,715 | 3,830 | 3,475 |
Minority Interest in Earnings | -271.18 | -232.45 | -491.67 | -255.38 | -101.74 |
Net Income | 1,818 | 891.87 | 2,223 | 3,574 | 3,373 |
Net Income to Common | 1,818 | 891.87 | 2,223 | 3,574 | 3,373 |
Net Income Growth | 103.82% | -59.89% | -37.80% | 5.96% | 65.40% |
Shares Outstanding (Basic) | 1,678 | 1,678 | 1,678 | 1,678 | 1,678 |
Shares Outstanding (Diluted) | 1,678 | 1,678 | 1,678 | 1,678 | 1,678 |
Shares Change (YoY) | 0.01% | -0.01% | -0.00% | 0.00% | 0.00% |
EPS (Basic) | 1.08 | 0.53 | 1.32 | 2.13 | 2.01 |
EPS (Diluted) | 1.08 | 0.53 | 1.32 | 2.13 | 2.01 |
EPS Growth | 103.80% | -59.88% | -37.80% | 5.96% | 65.39% |
Free Cash Flow | 1,847 | -961.7 | -2,943 | -1,632 | 1,869 |
Free Cash Flow Per Share | 1.10 | -0.57 | -1.75 | -0.97 | 1.11 |
Dividend Per Share | 0.434 | 0.225 | 0.560 | 0.660 | 0.635 |
Dividend Growth | 92.89% | -59.82% | -15.15% | 3.94% | 58.75% |
Gross Margin | 18.55% | 16.69% | 23.10% | 23.21% | 29.70% |
Operating Margin | 6.65% | 6.08% | 10.97% | 13.33% | 18.19% |
Profit Margin | 6.02% | 3.72% | 8.59% | 13.85% | 16.62% |
Free Cash Flow Margin | 6.12% | -4.01% | -11.37% | -6.32% | 9.21% |
EBITDA | 4,253 | 3,473 | 4,601 | 5,014 | 4,925 |
EBITDA Margin | 14.08% | 14.48% | 17.77% | 19.42% | 24.27% |
D&A For EBITDA | 2,246 | 2,016 | 1,762 | 1,572 | 1,235 |
EBIT | 2,007 | 1,458 | 2,840 | 3,442 | 3,691 |
EBIT Margin | 6.65% | 6.08% | 10.97% | 13.33% | 18.19% |
Effective Tax Rate | 10.96% | 7.91% | 10.59% | 7.79% | 15.73% |
Revenue as Reported | 30,195 | 23,984 | 25,893 | 25,814 | 20,295 |
Advertising Expenses | 12.2 | 13.3 | 8.7 | 2.83 | 4.09 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.